 
	
 
                                    
                                Because many patients with IBD receive immunosuppressive drugs, doctors have wondered whether those patients might be more susceptible to COVID-19, or its effects. On the other hand, immunomodulatory therapies might also suppress the hyperinflammatory cytokine response associated with the most severe presentations of COVID-19.
Dr. Lorenzo Norsa and colleagues observed 522 IBD patients in their clinic at the Papa Giovanni XXIII Hospital...
- Read Full Article...
- 5 comments
- 11,495 views
 Like
					
					Like
					
						 Thanks
					
					Thanks
					
						 Haha
					
					Haha
					
						 Confused
					
					Confused
					
						 Sad
					
					Sad
					
						 Upvote
					
					Upvote
					
						





.thumb.jpg.d8ccdbb71dd5d276bacf435aa9f4427d.jpg)
